SEPTInvestingStart Free

PCRX 8-K: Legal settlement

Filed with the SEC on · accession 0001140361-26-043437

PCRX filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +0.0% by the first close after the filing.

Summary of the filing

The Ninth Circuit Court of Appeals reversed in part a District Court judgment, holding that Pacira owes royalties to the Research Development Foundation on EXPAREL manufactured using its 200-liter process, while remanding for recalculation of interest owed to Pacira on the 45-liter portion.

For details, click here →How to read a 8-K →

Key details

Royalties paid under protest sought for repayment$23.1M
Statutory interest awarded on royalties paid under protest$5.2M
Cash payment received by Pacira$28.3M
RegistrantPacira BioSciences, Inc.
Counterparty in royalty disputeResearch Development Foundation
Chief administrative officer and secretaryKristen Williams

How PCRX stock reacted

Close before

$36.46

Nov 11, 2026

First close after

+0.00%

$36.46

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PCRX?

Click here

Frequently asked questions

What did PCRX file with the SEC on Nov 12, 2026?

PCRX filed a 8-K (Legal settlement). The Ninth Circuit Court of Appeals reversed in part a District Court judgment, holding that Pacira owes royalties to the Research Development Foundation on EXPAREL manufactured using its 200-liter process, while remanding for recalculation of interest owed to Pacira on the 45-liter portion.

What does a legal settlement mean for PCRX stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did PCRX stock react to this filing?

PCRX closed at $36.46 before the filing and $36.46 on Nov 12, 2026 (+0.00%).

Other PCRX SEC filings

Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PCRX overviewPCRX analysisPCRX newsLatest SEC filings